As of March 1, 2024, an article processing charge (APC) of USD 400 + 20% VAT will be requested for newly submitted research, review, meta-analysis articles to the Anatolian Journal of Cardiology if they are accepted for publication.
The Anatolian Journal of Cardiology
Antiplatelet Drugs for the Secondary Prevention of Coronary Heart Disease: Are They Without Problems? - European Cardiologist [Anatol J Cardiol]
Antiplatelet Drugs for the Secondary Prevention of Coronary Heart Disease: Are They Without Problems? - European Cardiologist
. Antiplatelet Drugs for the Secondary Prevention of Coronary Heart Disease: Are They Without Problems? - European Cardiologist. Anatol J Cardiol. 2001; 1(3): 219-221 Manuscript Language: English